Commonwealth Financial Services’s Novartis NVS Stock Holding History

Commonwealth Financial Services’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$32K	Buy	489 +21	+4%	+$1.4K	0.03%	120
2016 Q4	$30K	Sell	468 -58	-11%	-$3.76K	0.03%	114
2016 Q3	$37K	Hold	526	–	–	0.03%	94
2016 Q2	$39K	Hold	526	–	–	0.05%	96
2016 Q1	$34K	Hold	526	–	–	0.05%	94
2015 Q4	$41K	Hold	526	–	–	0.14%	77
2015 Q3	$43K	Hold	526	–	–	0.05%	81
2015 Q2	$46K	Hold	526	–	–	0.05%	93
2015 Q1	$46K	Hold	526	–	–	0.04%	95
2014 Q4	$44K	Buy	+526	New	+$43.6K	0.04%	89

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Financial Services's NVS Position: Q1 2017 in Review

Commonwealth Financial Services increased its Novartis (NVS) stake by 4.5% in Q1 2017, buying an estimated $1.4K and bringing the position to 489 shares worth $32K. The position accounts for 0.03% of the portfolio, ranked #120.

Commonwealth Financial Services first reported a position in NVS in Q4 2014 and has held it in 10 quarters since. The position peaked at $46K in Q2 2015. 910 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

Commonwealth Financial Services held 489 shares of Novartis worth $32K as of Q1 2017.
Commonwealth Financial Services bought 21 Novartis shares in Q1 2017, an estimated $1.4K.
Novartis made up 0.03% of Commonwealth Financial Services's portfolio in Q1 2017, its #120 holding.
Commonwealth Financial Services first reported a position in Novartis in Q4 2014 and has held it in 10 quarters since.
Commonwealth Financial Services's Novartis position peaked at $46K in Q2 2015.
910 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on Commonwealth Financial Services's 13F filing for Q1 2017, filed 20 Apr 2017.